Literature DB >> 3579564

Pelvic and sacropelvic exenteration for locally advanced or recurrent anorectal cancer.

N W Pearlman, R E Donohue, G V Stiegmann, D J Ahnen, S M Sedlacek, T J Braun.   

Abstract

Postirradiation "fixed" anorectal tumors are often considered incurable. Since 1980, we have carried out 12 pelvic and seven sacropelvic exenterations for this problem (adenocarcinoma, 18; squamous cancer, one). Nine tumors were primary; ten were recurrent (five after an anterior resection and five after an abdominoperineal resection). Prior irradiation ranged from 3000 to 12,000 rad (30 to 120 Gy). Four patients had synchronous distant metastases; three died of disease (one with local recurrence), and the fourth patient has been living with disease (distant metastasis). Fifteen patients (four with B2 tumors and 11 with Astler-Coller C2 disease) had no extrapelvic disease. One patient died of postoperative complications; two others died free of disease. Three of the 15 patients died of disease (all with local recurrence), and one has been living with disease (local recurrence). Eight (53%) of 15 patients have been living free of disease 12+ to 53+ months. The results suggest that many patients with fixed postirradiation anorectal tumors may be salvaged by aggressive surgery.

Entities:  

Mesh:

Year:  1987        PMID: 3579564     DOI: 10.1001/archsurg.1987.01400170043006

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  10 in total

1.  Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.

Authors:  Koh Ye Xin; Deanna Wan Jie Ng; Grace Hwei Ching Tan; Melissa Ching Ching Teo
Journal:  J Gastrointest Cancer       Date:  2014-09

Review 2.  Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives.

Authors:  Markus Rentsch; Tobias Schiergens; Andrej Khandoga; Jens Werner
Journal:  Visc Med       Date:  2016-06-13

Review 3.  Surgical management of locally advanced adenocarcinoma of the rectum.

Authors:  R M Devine; R R Dozois
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

Review 4.  Is total pelvic exenteration reasonable primary treatment for rectal carcinoma?

Authors:  L F Williams; C B Huddleston; J L Sawyers; J R Potts; K W Sharp; S W McDougal
Journal:  Ann Surg       Date:  1988-06       Impact factor: 12.969

5.  Composite resection of posterior pelvic malignancy.

Authors:  H J Wanebo; R J Koness; P S Turk; S I Cohen
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

6.  Total cystectomies in the surgical treatment of rectal cancer with prior chemoradiation: analysis of postoperative morbidity and survival.

Authors:  Janusz Oledzki; Maciej Chwaliński; Wojciech Rogowski; Rafał Sopyło; Marek P Nowacki
Journal:  Int J Colorectal Dis       Date:  2003-10-14       Impact factor: 2.571

7.  Follow-up in colorectal cancer patients: a cost-benefit analysis.

Authors:  R A Audisio; P Setti-Carraro; M Segala; D Capko; B Andreoni; G Tiberio
Journal:  Ann Surg Oncol       Date:  1996-07       Impact factor: 5.344

8.  Perineal wound closure with the rectus abdominis musculocutaneous flap after tumor ablation.

Authors:  W G de Haas; M J Miller; W J Temple; S S Kroll; M A Schusterman; G P Reece; J M Skibber
Journal:  Ann Surg Oncol       Date:  1995-09       Impact factor: 5.344

9.  Pelvic resection of recurrent rectal cancer.

Authors:  H J Wanebo; R J Koness; M P Vezeridis; S I Cohen; D E Wrobleski
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

10.  Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients.

Authors:  N O Funaki; J Tanaka; G Ohshio; H Onodera; S Maetani; M Imamura
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.